These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

67 related items for PubMed ID: 20952956

  • 1. Itraconazole versus griseofulvine in the treatment of tinea corporis and tinea cruris.
    Acharya KM, Mukhopadhyay A, Thakur RK, Mehta T, Bhuptani N, Patel R.
    Indian J Dermatol Venereol Leprol; 1995; 61(4):209-11. PubMed ID: 20952956
    [Abstract] [Full Text] [Related]

  • 2. Itraconazole compared with griseofulvin in the treatment of tinea corporis/cruris and tinea pedis/manus: an interpretation of the clinical results of all completed double-blind studies with respect to the pharmacokinetic profile.
    Lachapelle JM, De Doncker P, Tennstedt D, Cauwenbergh G, Janssen PA.
    Dermatology; 1992; 184(1):45-50. PubMed ID: 1313717
    [Abstract] [Full Text] [Related]

  • 3. A comparison of itraconazole and griseofulvin in the treatment of tinea corporis and tinea cruris: a double-blind study.
    Panagiotidou D, Kousidou T, Chaidemenos G, Karakatsanis G, Kalogeropoulou A, Teknetzis A, Chatzopoulou E, Michailidis D.
    J Int Med Res; 1992 Sep; 20(5):392-400. PubMed ID: 1333423
    [Abstract] [Full Text] [Related]

  • 4. A multicentre (double-blind) comparative study to assess the safety and efficacy of fluconazole and griseofulvin in the treatment of tinea corporis and tinea cruris.
    Faergemann J, Mörk NJ, Haglund A, Odegård T.
    Br J Dermatol; 1997 Apr; 136(4):575-7. PubMed ID: 9155961
    [Abstract] [Full Text] [Related]

  • 5. [Clinical study of itraconazole for the treatment of Tinea cruris, Tinea corporis and Tinea pedis interdigital].
    Zaitz C, Ruiz LR, Drullis EM, Gurfinkel P, Ciarnuto MA.
    Rev Inst Med Trop Sao Paulo; 1990 Apr; 32(4):299-303. PubMed ID: 1966257
    [Abstract] [Full Text] [Related]

  • 6. Oral treatment of tinea corporis and tinea cruris with terbinafine and griseofulvin: a randomized double blind comparative study.
    Voravutinon V.
    J Med Assoc Thai; 1993 Jul; 76(7):388-93. PubMed ID: 8089640
    [Abstract] [Full Text] [Related]

  • 7. Double-blind comparison of itraconazole with griseofulvin in the treatment of tinea corporis and tinea cruris.
    Bourlond A, Lachapelle JM, Aussems J, Boyden B, Campaert H, Conincx S, Decroix J, Geeraerts C, Ghekiere L, Morias J.
    Int J Dermatol; 1989 Jul; 28(6):410-2. PubMed ID: 2548967
    [Abstract] [Full Text] [Related]

  • 8. Clinical experience with short schedules of itraconazole in the treatment of tinea corporis and/or tinea cruris.
    Parent D, Decroix J, Heenen M.
    Dermatology; 1994 Jul; 189(4):378-81. PubMed ID: 7873824
    [Abstract] [Full Text] [Related]

  • 9. Double-blind comparison of itraconazole and placebo in the treatment of tinea corporis and tinea cruris.
    Pariser DM, Pariser RJ, Ruoff G, Ray TL.
    J Am Acad Dermatol; 1994 Aug; 31(2 Pt 1):232-4. PubMed ID: 8040406
    [Abstract] [Full Text] [Related]

  • 10. Once daily treatment with terbinafine 1% cream (Lamisil) for one week is effective in the treatment of tinea corporis and cruris. A placebo-controlled study.
    Budimulja U, Bramono K, Urip KS, Basuki S, Widodo G, Rapatz G, Paul C.
    Mycoses; 2001 Aug; 44(7-8):300-6. PubMed ID: 11714065
    [Abstract] [Full Text] [Related]

  • 11. A double blind study of itraconazole vs griseofulvin in patients with tinea pedis and tinea manus.
    Wishart JM.
    N Z Med J; 1994 Apr 13; 107(975):126-8. PubMed ID: 8145958
    [Abstract] [Full Text] [Related]

  • 12. Itraconazole in the treatment of tinea corporis and tinea cruris.
    Katsambas A, Antoniou C, Frangouli E, Rigopoulos D, Vlachou M, Michailidis D, Stratigos J.
    Clin Exp Dermatol; 1993 Jul 13; 18(4):322-5. PubMed ID: 8403466
    [Abstract] [Full Text] [Related]

  • 13. [Comparative evaluation of fluconazole 50 mg and 100 mg versus itraconazole 100 mg in the treatment of dermatomycoses].
    Lospalluti M, Barile F, Pantaleo AK, Conese M, Guerra AP, Lo Re M, D'Amico G, Barbieri G.
    Clin Ter; 1994 Feb 13; 144(2):129-38. PubMed ID: 8181207
    [Abstract] [Full Text] [Related]

  • 14. Comparative efficacy of topical 1% butenafine and 1% clotrimazole in tinea cruris and tinea corporis: a randomized, double-blind trial.
    Singal A, Pandhi D, Agrawal S, Das S.
    J Dermatolog Treat; 2005 Feb 13; 16(5-6):331-5. PubMed ID: 16428155
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Predicting a therapeutic cut-off serum level of itraconazole in recalcitrant tinea corporis and cruris-A prospective trial.
    Khurana A, Agarwal A, Singh A, Sardana K, Ghadlinge M, Agrawal D, Panesar S, Sethia K, Chowdhary A.
    Mycoses; 2021 Dec 13; 64(12):1480-1488. PubMed ID: 34532888
    [Abstract] [Full Text] [Related]

  • 17. Comparative study between terbinafine 1% emulsion-gel versus ketoconazole 2% cream in tinea cruris and tinea corporis.
    Bonifaz A, Saúl A.
    Eur J Dermatol; 2000 Mar 13; 10(2):107-9. PubMed ID: 10694308
    [Abstract] [Full Text] [Related]

  • 18. Management of fungal skin infections with 15 days itraconazole treatment: a worldwide review.
    De Doncker P, Cauwenbergh G.
    Br J Clin Pract Suppl; 1990 Sep 13; 71():118-22. PubMed ID: 1965415
    [Abstract] [Full Text] [Related]

  • 19. Randomised controlled trial of topical butenafine in tinea cruris and tinea corporis.
    Ramam M, Prasad HR, Manchanda Y, Khaitan BK, Banerjee U, Mukhopadhyaya A, Shetty R, Gogtay JA.
    Indian J Dermatol Venereol Leprol; 2003 Sep 13; 69(2):154-8. PubMed ID: 17642865
    [Abstract] [Full Text] [Related]

  • 20. Treatment of dermatophytosis with new systemic antifungal agent, itraconazole.
    Noppakun N, Phuphaibool K.
    J Med Assoc Thai; 1992 Feb 13; 75(2):99-103. PubMed ID: 1322949
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.